Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2007
11/01/2007US20070254325 Method and device for the determination of platelet function under flow conditions
11/01/2007US20070254324 Method for determination of platelet function under flow conditions
11/01/2007US20070254321 Lytic Enzymes and Spore Surface Antigen for Detection and Treatment of Bacillus Anthracis Bacteria and Spores
11/01/2007US20070254320 Method and Kit for Detecting Listeria Spp.
11/01/2007US20070254312 Protein Kinase Inhibitors and Methods for Identiying Same
11/01/2007US20070254306 Method of determining genetic predisposition for deficiency in health functions using SNP analysis
11/01/2007US20070254305 Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissue
11/01/2007US20070254304 Helicase-dependent amplification of nucleic acids
11/01/2007US20070254303 Methods for assessing the efficacy of treatment with a glucocorticoid
11/01/2007US20070254302 Compositions and methods for the diagnosis and treatment of tumor
11/01/2007US20070254301 Compositions and methods for detecting protease activity
11/01/2007US20070254300 Compositions and methods for treating inflammatory disorders
11/01/2007US20070254299 Fungal delta 12 desaturase and delta 15 desaturase motifs
11/01/2007US20070254298 Atropisomers of asymmetric xanthene fluorescent dyes and method of dna sequencing and fragment analysis
11/01/2007US20070254297 KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies
11/01/2007US20070254296 Using allelic variation in corticotropin-releasing hormone (CRH) gene expression profiles as evaluative tools in monitoring/prognosing meat quality; animal husbandry; veterinary medicine
11/01/2007US20070254295 Methods of predicting and monitoring tyrosine kinase inhibitor therapy
11/01/2007US20070254294 Method for Storing Dna by Using Chitosan, and Products Using the Methods
11/01/2007US20070254293 Method for the Analysis of Methylated Dna
11/01/2007US20070254292 Method for Trapping Nucleic Acids Using Divalent Metal Ions
11/01/2007US20070254291 Gene Targeting in Eukaryotic Cells by Group II Intron Ribonucleoprotein Particles
11/01/2007US20070254290 Biomarkers for diagnosis of crescentic glomerulonephritis
11/01/2007US20070254289 Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
11/01/2007US20070254288 Diagnostic methods for pain sensitivity and chronicity and for tetrahydrobiopterin-related disorders
11/01/2007US20070254287 Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 10 (Dpp10)
11/01/2007US20070254286 Molecular Markers that predict breast cancer development
11/01/2007US20070254285 Stable water-soluble polyethylenimine conjugates and methods of use thereof
11/01/2007US20070254284 A nucleic acid detection method
11/01/2007US20070254283 Brhf1 as a Cancer Diagnostic Marker
11/01/2007US20070254282 Catalytic Polynucleotide and Its Use for Determination of Analytes
11/01/2007US20070254281 Specific Marker Lmx1a on Dopaminergic Neurons
11/01/2007US20070254280 Method of Identifying Characteristic of Molecules
11/01/2007US20070254279 Single molecule drug discovery
11/01/2007US20070254277 Automated systems for handling specimens for laboratory diagnostics and associating relevant information
11/01/2007US20070254276 Method and system for measuring membrane potential based on fluorescence polarization
11/01/2007US20070253978 Copy choice recombination and uses thereof
11/01/2007US20070253974 Elicits the production of antibodies that interfere with invasion by Babesia bovis into erythrocytes, diagnosis
11/01/2007US20070253954 Epha4 As Therapeutic Target Of Prc And Pdaca
11/01/2007US20070253953 Molecular Signature of the Pten Tumor Suppressor
11/01/2007US20070253949 Diagnostics and Therapeutics for Diseases Associated with Plasma Kallikrein (KLKB1)
11/01/2007US20070253906 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease
11/01/2007US20070253905 Abeta42 LOWERING AGENTS
11/01/2007US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007US20070251871 Integrated high throughput system for the analysis of biomolecules
11/01/2007CA2650079A1 A sex-specific marker for shrimps and prawns
11/01/2007CA2649920A1 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
11/01/2007CA2649770A1 Mutated acvr1 for diagnosis and treatment of fibrodyplasia ossificans progressiva (fop)
11/01/2007CA2649732A1 Methods for detecting mutations in jak2 nucleic acid
11/01/2007CA2649583A1 Methods and kits for early stage caries detection
11/01/2007CA2649295A1 Methods for high-throughput screening of cell lines
11/01/2007CA2648030A1 Compositions and methods comprising the use of cell surface displayed homing endonucleases
11/01/2007CA2647671A1 Treatment of tumors expressing mutant egf receptors
11/01/2007CA2647099A1 Therapeutic target molecules for the development of novel medicaments for degenerative diseases
11/01/2007CA2646526A1 Methods and compositions for expressing negative-sense viral rna in canine cells
11/01/2007CA2633715A1 Translational dysfunction based therapeutics
10/2007
10/31/2007EP1850132A1 Method for determining the ratio of two distinct peptides or polynucleic acids
10/31/2007EP1850130A1 Gene markers and utilzation of the same
10/31/2007EP1849878A1 Means and methods for diagnosing and treating cancer based on the frmd3 gene
10/31/2007EP1849877A1 Replicative history of T-and B-cell subsets
10/31/2007EP1849876A1 Method, reagent and kit for quantifying cholesterol in remnant-like lipoprotein (rlp)
10/31/2007EP1849875A2 Method for determining total homocysteine
10/31/2007EP1849870A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (IDDM)
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849868A2 Plant defensins
10/31/2007EP1849864A1 Method for determining phospholipidosis
10/31/2007EP1849861A1 Method and apparatus for separating cells
10/31/2007EP1849846A2 Method for chemiluminescent detection
10/31/2007EP1849802A2 Methods for altering fertility
10/31/2007EP1849522A1 An inspection chip for biological material
10/31/2007EP1848999A2 Fecal sample test device and methods of use
10/31/2007EP1848994A2 Methods and systems for diagnosis, prognosis and selection of treatment of leukemia
10/31/2007EP1848990A1 Sensor for detection of single molecules
10/31/2007EP1848988A2 Electrochemical sensing method
10/31/2007EP1848829A2 Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
10/31/2007EP1848828A1 Hpv e6, e7 mrna assay and methods of use thereof
10/31/2007EP1848827A2 Methods and compositions for tagging and identifying polynucleotides
10/31/2007EP1848826A2 Human autism susceptibility gene encoding a kinase and uses thereof
10/31/2007EP1848825A2 Methods of predicting chemotherapy responsiveness in breast cancer patients
10/31/2007EP1848824A1 Selected compaction agents and methods and compositions for biotechnical separations
10/31/2007EP1848823A2 Methods for separating short single-stranded nucleic acid from long single- and double-stranded nucleic acid, and associated biomolecular assays
10/31/2007EP1848822A1 Method of diagnosing type ii diabetes mellitus using multilocus marker, polynucleotide including marker associated with type ii diabetes mellitus, and microarray and diagnostic kit including the polynucleotide
10/31/2007EP1848821A1 Polynucleotide associated with breast cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing breast cancer using the same
10/31/2007EP1848820A2 Vagal afferent neurons as targets for treatment
10/31/2007EP1848819A1 Methods of genetic analysis involving the amplification of complementary duplicons
10/31/2007EP1848818A1 Identification of molecular diagnostic markers for endometriosis in blood lymphocytes
10/31/2007EP1848817A1 Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides
10/31/2007EP1848816A1 Screening method for hiv rt inhibitors
10/31/2007EP1848815A1 Esterases for monitoring protein biosynthesis in vitro
10/31/2007EP1848814A1 Screening method for identifying protease secretion-deficient mutants of microorganisms
10/31/2007EP1848807A1 Transcription regulating nucleotide sequence from solanaceae triose-phosphate translocator genes and their use in plant expression cassettes
10/31/2007EP1848801A1 Composition and methods for protein design
10/31/2007EP1848793A2 Polyelectrolyte-coated ion-exchange particles
10/31/2007EP1848741A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype
10/31/2007EP1848739A2 Adamts-7 as a biomarker for cancers of epithelial origin
10/31/2007EP1848504A2 Wound treatment device for photodynamic therapy and method of using same
10/31/2007EP1848436A2 Methods of diagnosis and treatment for asthma, allergic rhinitis and other respiratory diseases based on haplotype association
10/31/2007EP1766044A4 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
10/31/2007EP1759006A4 Galnts as modifiers of the igfr pathway and methods of use
10/31/2007EP1730287A4 Inducible promoters
10/31/2007EP1725869A4 Man2as as modifiers of the iger pathway and methods of use
1 ... 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 ... 3003